CKMH Overweight / Obesity
There is no content available at this time. Please check again later.
Relevant Content
Comprehensive Clinical Approach to Cardiovascular Kidney Metabolic Syndrome
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Cardiovascular Risk Reduction With GLP-1 RA Drugs
Circulation, Volume 154, Issue 1, Page 66-73, July 7, 2026.
GLP-1 (gl...
Researchers at Heart
GLP-1 (gl...
Circulation: Population Health and Outcomes, Ahead of Print.
BACKGROU...
Strategies for Optimizing Heart Failure Care in the Older Adult
BACKGROU...
Heart failure (HF) in older adults is a growing and distinct clinical chal...
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease
The American Heart Association Predicting Risk of Cardiovascular Disease E...
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
Guideline offering updated evidence on cardiovascular‑kidney‑metabolic syn...
Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up After 2 Clinical Trials
Circulation, Ahead of Print.
BACKGROUND:During the 18-month CENTRAL (...
Incretin-Based Therapies and Cardiovascular Outcomes: Beyond Weight Loss
BACKGROUND:During the 18-month CENTRAL (...
Circulation, Volume 153, Issue 20, Page 1523-1525, May 19, 2026.